End-stage liver disease (ESLD), stemming from a spectrum of chronic liver pathologies
including chronic liver failure, acute cirrhosis decompensation and hepatocellular …

In liver transplantation, older donor age is a well-known risk factor for dismal outcomes,
especially due to the high susceptibility of older grafts to ischemia-reperfusion injury …

Concepts to ameliorate the continued mismatch between demand for liver allografts and
supply include the acceptance of allografts that meet extended donor criteria (ECD). ECD …

Ex vivo liver machine perfusion (MP) is a promising alternative for preservation of liver grafts
from extended criteria donors. Small animal models can be used to evaluate different …

Background: Pediatric liver transplantation (LT) is the treatment of choice for children with
end-stage liver disease and in certain cases of hepatic malignancies. Due to low case …

The major extended donor criteria (maEDC; steatosis> 40%, age> 65 years, and cold
ischemia time> 14 h) influence graft and patient outcomes after liver transplantation. Despite …

Liver transplantation is the only curative treatment option for end‐stage liver disease. As the
population ages worldwide, utilization of grafts from elderly donors has the potential to …

Liver grafts are frequently declined due to high donor age or age mismatch with the
recipient. To improve the outcome of marginal grafts, we aimed to characterize the …

Аннотация Цель исследования–изучение различий в частоте патологических
процессов в биоптатах печени доноров старше 60 лет (I группа) и доноров, признанных …

Die Lebertransplantation (LTX) wird bereits seit mehreren Jahrzehnten zur Therapie bei
akuten und chronischen Lebererkrankungen eingesetzt. Angefangen mit der ersten …